⌘K
Loading ticker…
Assembly Biosciences, Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Assembly Biosciences, Inc (ASMB) has a 3-month relative strength percentile of 29 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.9%, relative volume 7.75×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
29 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ASMB is in a stage 1 base, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -0.3% / -7.6%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
ASMB is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $10M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $10M |
| VXFVanguard Extended Market ETF | 0.00% | $4M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ASMB Jan avg: 3.26% median: 1.71% win: 50% σ: 26.01% n: 4 2022-04-12 → 2026-05-29 | ASMB Feb avg: -0.19% median: 2.65% win: 50% σ: 17.98% n: 4 2022-04-12 → 2026-05-29 | ASMB Mar avg: -16.75% median: -16.39% win: 25% σ: 18.86% n: 4 2022-04-12 → 2026-05-29 | ASMB Apr avg: 2.90% median: -2.88% win: 40% σ: 18.07% n: 5 2022-04-12 → 2026-05-29 | ASMB May avg: 9.79% median: 8.52% win: 80% σ: 13.34% n: 5 2022-04-12 → 2026-05-29 | ASMB Jun avg: 12.16% median: 15.01% win: 75% σ: 16.19% n: 4 2022-04-12 → 2026-05-29 (current) | ASMB Jul avg: 0.12% median: -1.25% win: 25% σ: 4.35% n: 4 2022-04-12 → 2026-05-29 | ASMB Aug avg: 7.16% median: 0.83% win: 50% σ: 22.82% n: 4 2022-04-12 → 2026-05-29 | ASMB Sep avg: -6.54% median: -8.74% win: 25% σ: 7.15% n: 4 2022-04-12 → 2026-05-29 | ASMB Oct avg: 7.85% median: 5.51% win: 50% σ: 10.47% n: 4 2022-04-12 → 2026-05-29 | ASMB Nov avg: -4.30% median: -9.38% win: 50% σ: 20.09% n: 4 2022-04-12 → 2026-05-29 | ASMB Dec avg: -0.26% median: -4.08% win: 25% σ: 12.23% n: 4 2022-04-12 → 2026-05-29 |